Altshuler Shaham LTD Biomarin Pharmaceutical Inc Transaction History

Altshuler Shaham LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$87.74 - $117.27 $22,461 - $30,021	-256 Closed	0 $0
Q4 2022 May 09, 2023	SELL	$80.93 - $108.63 $2,913 - $3,910	-36 Reduced 12.33%	256 $26,000
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $23,990 - $28,306	292 New	292 $25,000
Q2 2022 Aug 10, 2022	SELL	$71.48 - $86.85 $36,812 - $44,727	-515 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $38,254 - $47,735	515 New	515 $40,000
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $37,516 - $68,397	-522 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $29,353 - $45,837	369 Added 241.18%	522 $64,000
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $10,348 - $14,043	145 Added 1812.5%	153 $13,000
Q4 2019 Feb 11, 2020	BUY	$64.27 - $86.37 $514 - $690	8 New	8 $1,000

638

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.